Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Joint development agreement signed by Beaufour Ipsen and Roche for new anticancer drugs

Jan. 3, 2003

Oxigene begins phase II trial of CA4P in thyroid cancer

Jan. 3, 2003

Discovery of Src kinase inhibitors reported by AstraZeneca

Jan. 2, 2003

New caspase activators and their use in cancer and autoimmune diseases

Jan. 2, 2003

Gleevec granted FDA approval for first-line treatment of CML

Jan. 2, 2003

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

Jan. 2, 2003

Onconase receives fast track designation for malignant mesothelioma

Jan. 2, 2003

PSMA Development prostate cancer vaccine enters phase I

Jan. 2, 2003

GlycoGenesys acquires Elan's interest in joint venture

Jan. 2, 2003

Novel paclitaxel formulation ABI-007 evaluated in cancer patients

Jan. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...